Business Services Industry

Affymax® to Present at the UBS Global Life Sciences Conference

Business Wire, Sept 19, 2007

PALO ALTO, Calif. -- Affymax, Inc. (Nasdaq: AFFY) today announced that Paul Cleveland, the company's executive vice president and chief financial officer, will present at the UBS Life Sciences Conference on Wednesday, September 26, at 10:30 a.m. Eastern Daylight Time in New York.

A live webcast of the presentation will be available on the Investors section of the company's website at www.affymax.com. A replay will also be available for 30 days following the presentation.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax's lead product candidate, Hematide[TM], is currently in Phase 3 clinical trial stage for the treatment of anemia associated with chronic renal failure and in clinical trials for the treatment of anemia in cancer patients. For additional information, please visit www.affymax.com.

COPYRIGHT 2007 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Content provided in partnership with Thompson Gale